Rare diseases
Investigational molecules
Locations
Recruiting trials first
9 clinical trials in this condition
Germany
Denmark
Hungary
SpainIn short
Bronchopulmonary dysplasia is a lung condition affecting premature babies who need oxygen support or mechanical breathing assistance after birth. Understanding how doctors identify and monitor this condition helps families prepare for the journey ahead and work closely with medical teams to support their baby's recovery and long-term health.
Bronchopulmonary dysplasia, often called BPD, is not something babies are born with. Instead, it develops as a complication in newborns who need prolonged breathing support. The babies most at risk are those born more than 10 weeks before their due date, weighing less than 2 pounds at birth, or experiencing serious breathing problems shortly after delivery. When a baby arrives this early, their lungs are simply not ready to work on their own, and they require help from oxygen therapy or ventilators to breathe.
Parents should be aware that not every premature baby will develop this condition, but those who need continuous breathing support are monitored closely. Doctors pay special attention to babies who show signs of respiratory distress, such as rapid breathing, a bluish tone to the skin (called cyanosis), pauses in breathing, or wheezing. It's rare for babies born after 32 weeks of pregnancy to develop BPD, so the timing of birth matters significantly.
The medical team will watch your baby carefully throughout their stay in the neonatal intensive care unit, or NICU. This is the specialized hospital area where premature and sick newborns receive round-the-clock care. If your baby needs oxygen or mechanical ventilation for an extended period, the healthcare providers will begin diagnostic assessments to determine whether BPD is developing. Early detection allows the team to adjust treatment strategies and support your baby's lung growth and healing.
There is no single test that can instantly tell doctors whether a baby has bronchopulmonary dysplasia. Instead, the diagnosis relies on observing your baby's breathing needs over time and looking at how their lungs appear on imaging tests. The main way doctors identify BPD is by noting whether a baby still requires breathing support after a certain point in their development.
If your baby is born before 32 weeks and still needs oxygen or respiratory support at 36 weeks postmenstrual age—which means the number of weeks since your last menstrual period began, combining the weeks of pregnancy with the weeks since birth—this suggests BPD. For babies born after 32 weeks, the diagnosis is considered if they need more than 21% oxygen (which is higher than regular room air) for at least 28 days after birth. These time frames help doctors distinguish BPD from temporary breathing difficulties that many premature babies experience initially.
Chest X-rays play an important role in understanding what is happening inside your baby's lungs. Early in the condition, the X-ray may show a diffuse haziness caused by fluid buildup. As time passes, the appearance can change to show a multicystic or sponge-like pattern, with some areas of the lung appearing overinflated while others look collapsed or scarred. These changes reflect the ongoing damage and healing processes occurring in the delicate lung tissue.
Blood tests are another tool doctors use to monitor babies with suspected BPD. These tests measure how much oxygen is present in your baby's blood, helping the medical team understand whether the lungs are effectively transferring oxygen into the bloodstream. If oxygen levels remain low despite breathing support, this indicates the lungs are struggling and may be affected by BPD.
Some babies with BPD also develop a complication called pulmonary hypertension, which means increased pressure in the blood vessels that carry blood from the heart to the lungs. To check for this, doctors may order an echocardiogram, which is an ultrasound of the heart. This test allows them to see how well the heart is pumping and whether the pressure in the pulmonary arteries is elevated. Babies with moderate or severe BPD typically undergo this screening after reaching 36 weeks postmenstrual age.
Doctors also watch for visible signs of respiratory distress, which can include rapid breathing (called tachypnea), flaring nostrils, grunting sounds, and pulling in of the chest between the ribs with each breath (known as retractions). These physical signs tell the medical team that your baby is working very hard to breathe, and they provide clues about the severity of the lung condition.
In some cases, doctors may examine fluid from the baby's lungs by looking at a sample from the trachea, the windpipe. This fluid can contain cells and substances that indicate inflammation and damage, though this is not a routine test for every baby.
Clinical trials are research studies that test new treatments or approaches to managing bronchopulmonary dysplasia. When doctors consider enrolling a baby in a clinical trial, they use specific diagnostic criteria to ensure the child qualifies and to group babies with similar severity levels together. These criteria help researchers understand whether a new treatment is working and for which babies it might be most helpful.
The most common qualification standard is based on how much oxygen and respiratory support a baby needs at 36 weeks postmenstrual age. Researchers have developed grading systems that classify BPD as mild, moderate, or severe depending on these factors. A baby with mild BPD might be breathing room air by this point, while a baby with severe BPD may still require mechanical ventilation or high levels of supplemental oxygen.
Imaging tests, particularly chest X-rays, help researchers document the extent of lung damage and track changes over time. These images provide a baseline before treatment begins and allow comparison after the trial intervention. Similarly, blood oxygen measurements taken through arterial blood gas tests or continuous monitoring with a pulse oximeter—a small device placed on the baby's hand or foot—are used to track how well a baby's lungs are functioning throughout a study.
Some clinical trials may also require an echocardiogram to rule out or confirm pulmonary hypertension before enrollment. This ensures that researchers are studying babies with BPD specifically, rather than those whose breathing problems stem primarily from heart complications.
Babies in clinical trials undergo additional testing to monitor their growth, nutrition, and developmental progress. This might include measurements of weight, length, and head circumference taken at regular intervals, as well as assessments of feeding tolerance and the need for specialized nutrition through feeding tubes. These measurements help researchers understand whether a new treatment not only improves breathing but also supports overall health and development.
Before any baby can be enrolled in a clinical trial, parents must give informed consent after understanding the study's purpose, potential risks, and benefits. The research team will explain exactly what diagnostic tests will be performed and how often. Participation is always voluntary, and families can withdraw at any time without affecting their baby's standard medical care.
Most infants with bronchopulmonary dysplasia recover over time, though the journey can vary significantly from one baby to another. The severity of the condition at diagnosis plays a major role in determining long-term outcomes. Babies with mild BPD often show improvement within the first few years of life, while those with moderate or severe forms may experience ongoing breathing difficulties and require continued medical support.
Many children with BPD grow out of the worst symptoms by the time they reach 5 years old, though some may continue to have sensitive airways that make them prone to wheezing, coughing, or difficulty breathing during respiratory infections. The developing lungs gradually catch up, forming new airways and blood vessels, though the lung function may never be completely normal in children who had severe disease.
Beyond lung health, babies with BPD face an increased risk of other health challenges. Feeding difficulties are common because the effort of breathing can make it hard for babies to coordinate sucking and swallowing. Some may need feeding tubes to ensure they receive adequate nutrition for growth. Problems with vision and hearing, delayed speech, and learning difficulties can also occur, as the same factors that led to lung damage may have affected other developing organs. Regular developmental follow-up is important for identifying and addressing these issues early.
Children who had BPD as infants are more vulnerable to certain respiratory infections, particularly respiratory syncytial virus (RSV), which can cause severe illness requiring hospitalization. They may also develop asthma, bronchitis, or reactive airway disease as they grow older. These conditions can usually be managed with medications and preventive measures, but families should remain alert to breathing problems and work closely with healthcare providers.
The introduction of modern neonatal care, including surfactant therapy and gentler ventilation strategies, has dramatically improved survival rates for premature babies at risk of bronchopulmonary dysplasia. While specific survival statistics for BPD vary by birth weight and gestational age, the condition itself is not typically fatal when managed in a well-equipped neonatal intensive care unit. However, babies with severe BPD do face higher risks of complications that can threaten survival, particularly if pulmonary hypertension or severe infections develop.
Research shows that between 40% and 68% of very low birth weight infants—those weighing less than 1,500 grams (about 3.3 pounds)—develop BPD, with rates increasing as birth weight and gestational age decrease. Among these babies, most survive and eventually recover enough to leave the hospital, though the timeline varies. Some infants may need to stay in the NICU for several months while their lungs heal and grow strong enough to support breathing without assistance.
The prognosis has improved significantly over the decades, with babies who would not have survived in earlier eras now thriving into childhood and adulthood. However, those born at extremely low gestational ages—particularly before 28 weeks—remain at the highest risk for severe disease and potential life-threatening complications. Approximately 20% of babies with severe BPD may not survive, though this statistic continues to improve as medical science advances. Ongoing medical follow-up and appropriate intervention when complications arise are essential for the best possible outcomes.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
